PMA device
Staarvisc II & Shellgel Sodium Hyauronate
Anika Therapeutics, Inc. · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Dec 3, 2002, newest Mar 27, 2012Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
0
Naming "Staarvisc II Shellgel"
MAUDE reports
0
Brand "Staarvisc II Shellgel", since 2015
PubMed studies
0
Mentioning "Staarvisc II Shellgel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Staarvisc II & Shellgel Sodium Hyauronate
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- STAARVISC II & SHELLGEL SODIUM HYAURONATEPMA supplement
P000046-S015 · Decided Mar 27, 2012 · 1,035 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
- STAARVISC II & SHELLGEL SODIUM HYALURONATEPMA supplement
P000046-S017 · Decided Jan 17, 2012 · 474 days after receipt · Normal 180 Day Track No User Fee
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
P000046-S007 · Decided Mar 12, 2003 · 105 days after receipt · Normal 180 Day Track
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Staarvisc II Shellgel", any status and sponsor, newest update first.
No registered device study names "Staarvisc II Shellgel".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Staarvisc II Shellgel", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZP
1,607 reports: 550 malfunction, 1,056 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Staarvisic II Sodium Hyaluronate, 0.8 mLTerminated
Z-1106-05 · Started Jul 18, 2005 · Posted by FDA Aug 6, 2005
Reason given: Sterility may be compromised.
Cause as FDA categorized it: Other · Device type: Aid, Surgical, Viscoelastic (LZP)
Z-1382-05 · Started Jul 14, 2005 · Posted by FDA Aug 23, 2005
Reason given: Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe.
Cause as FDA categorized it: Other · Device type: Aid, Surgical, Viscoelastic (LZP)
Z-1383-05 · Started Jul 14, 2005 · Posted by FDA Aug 23, 2005
Reason given: Product sterility may be compromised due incomplete heat seals in the cannula pouches that are included with the viscoelastic syringe.
Cause as FDA categorized it: Other · Device type: Aid, Surgical, Viscoelastic (LZP)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Staarvisc II Shellgel"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LZP.
- PROVISC Ophthalmic Viscosurgical DeviceAlcon Research, Ltd. · PMA 2026
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- DISCOVISC Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2021
- Cellugel(R) Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2016
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
- Biolon (1% Sodium Hyaluronate for Ophthalmic Surgery)Altacor , Ltd. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.